S. L. Greenspan
- Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research 50
- Bone and Joint Diseases 16
- Oncology top 2%
- Bone health and treatments 38
- Behavioral Neuroscience top 5%
-
- Vitamin D Research Studies 6
-
- Hip and Femur Fractures 11
-
- Bone Metabolism and Diseases 8
-
- Parathyroid Disorders and Treatments 6
-
- Nutrition and Health in Aging 6
S. L. Greenspan
72 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Orthopedics and Sports Medicine 2.6k
- Oncology 1.6k
- Behavioral Neuroscience 92
- Pathology and Forensic Medicine 446
- Endocrinology, Diabetes and Metabolism 390
Countries citing papers authored by S. L. Greenspan
This map shows the geographic impact of S. L. Greenspan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. L. Greenspan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. L. Greenspan more than expected).
Fields of papers citing papers by S. L. Greenspan
This network shows the impact of papers produced by S. L. Greenspan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. L. Greenspan. The network helps show where S. L. Greenspan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. L. Greenspan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The clinician’s guide to prevention and treatment of osteoporosisbreakdown → | 2022 | 623 |
| 2 | 2021 | 24 | |
| 3 | 2020 | 5 | |
| 4 | 2016 | 27 | |
| 5 | Phase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design | 2013 | 3 |
| 6 | 2013 | 38 | |
| 7 | 2012 | 77 | |
| 8 | Phase 3 Fracture Trial of Odanacatib for Osteoporosis - Study Design | 2010 | 1 |
| 9 | 2009 | 23 | |
| 10 | Risedronatın kalçanın yapısal geometrisi üzerine etkisi: Kemoterapi ile indüklenmiş menopoz sonrası kadınlarda yapılan bir yıl süreli çift-kör bir klinik çalışma | 2009 | 1 |
| 11 | 2006 | 94 | |
| 12 | 2005 | 52 | |
| 13 | 2005 | 21 | |
| 14 | 1999 | 26 | |
| 15 | 1998 | 63 | |
| 16 | 1997 | 15 | |
| 17 | 1995 | 75 | |
| 18 | 1994 | 8 | |
| 19 | 1994 | 148 | |
| 20 | 1994 | 8 |
About S. L. Greenspan
S. L. Greenspan is a scholar working on Orthopedics and Sports Medicine, Oncology and Nephrology, having authored 73 papers that have together received 4.0k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (50 papers), Bone health and treatments (38 papers), Bone and Joint Diseases (16 papers), Hip and Femur Fractures (11 papers), Bone Metabolism and Diseases (8 papers), Vitamin D Research Studies (6 papers), Parathyroid Disorders and Treatments (6 papers) and Nutrition and Health in Aging (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.6k citations), Oncology (1.6k citations) and Behavioral Neuroscience (92 citations). S. L. Greenspan has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Kenneth G. Saag, Ethel S. Siris, Andrea Singer, Meryl S. LeBoff, Harold N. Rosen, E. Michael Lewiecki, Karl Insogna, A C Moses, Rivka Dresner–Pollak and Serge Ferrari. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.